Researchers continue exploring how hemp-derived cannabinoids may interact with cellular stress and inflammatory pathways involved in disease progression. In the study “Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells,” scientists investigated how cannabigerol (CBG) affected human pancreatic cancer cells in laboratory models. The findings showed that CBG triggered multiple forms of programmed cell death linked to cellular stress responses and oxidative damage. (PubMed)

The study found that CBG activated what is known as the unfolded protein response, specifically involving the IRE1α-XBP1 signaling pathway. Researchers observed that CBG increased markers associated with apoptosis and ferroptosis, two important biological processes connected to damaged or dysfunctional cell removal. The research also showed changes in oxidative stress and inflammation-related proteins, including NRF2, HO-1, and CHOP, which are involved in how cells respond to stress and injury. (The Marijuana Herald)

Scientists noted that this research remains preclinical and was conducted in laboratory cancer cell models, not human clinical trials. However, studies like this continue expanding scientific understanding of how cannabinoids such as CBG may interact with inflammatory signaling, oxidative stress, and cellular balance pathways throughout the body. As cannabinoid science evolves, researchers continue investigating the unique biological properties of minor cannabinoids and their potential role in future therapeutic research. (PubMed)

Source

Park JH, et al. Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells. Published March 2026. (PubMed) https://pubmed.ncbi.nlm.nih.gov/41871732/